Abbott to buy Galapagos arthritis-drug rights for up to $1.35 billion
By Bloomberg.com
Posted: February 29, 2012 - 1:45 pm ET
Tags:
Abbott Laboratories agreed to pay Galapagos as much as $1.35 billion for rights to an experimental rheumatoid arthritis drug that would compete with a Pfizer pill.
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.